产品: ARG1 抗体
货号: DF6657
描述: Rabbit polyclonal antibody to ARG1
应用: WB IHC IF/ICC
文献验证: WB, IHC, IF/ICC
反应: Human, Mouse, Rat
预测: Pig, Xenopus
蛋白号: P05089
RRID: AB_2838619

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1250 现货
 100ul RMB¥ 2300 现货
 200ul RMB¥ 3000 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user. For optimal experimental results, antibody reuse is not recommended.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat
克隆:
Polyclonal
特异性:
ARG1 Antibody detects endogenous levels of total ARG1.
RRID:
AB_2838619
引用格式: Affinity Biosciences Cat# DF6657, RRID:AB_2838619.
偶联:
Unconjugated.
纯化:
The antiserum was purified by peptide affinity chromatography using SulfoLink™ Coupling Resin (Thermo Fisher Scientific).
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

A I; Al; ARG 1; arg1; ARGI1_HUMAN; Arginase 1; Arginase liver; Arginase type I; Arginase, liver; Arginase-1; Arginase1; Liver type arginase; Liver-type arginase; Type I arginase;

抗原和靶标

免疫原:

A synthesized peptide derived from human ARG1, corresponding to a region within C-terminal amino acids.

基因/基因ID:
描述:
Arginase catalyzes the hydrolysis of arginine to ornithine and urea. At least two isoforms of mammalian arginase exist (types I and II) which differ in their tissue distribution, subcellular localization, immunologic crossreactivity and physiologic function. The type I isoform encoded by this gene, is a cytosolic enzyme and expressed predominantly in the liver as a component of the urea cycle. Inherited deficiency of this enzyme results in argininemia, an autosomal recessive disorder characterized by hyperammonemia. Two transcript variants encoding different isoforms have been found for this gene.

研究领域

· Human Diseases > Infectious diseases: Parasitic > Amoebiasis.

· Metabolism > Amino acid metabolism > Arginine biosynthesis.

· Metabolism > Amino acid metabolism > Arginine and proline metabolism.

· Metabolism > Global and overview maps > Metabolic pathways.

· Metabolism > Global and overview maps > Biosynthesis of amino acids.

文献引用

1). Microenvironment-responsive multifunctional enzyme-linked hydrogel for diabetic bone defect regeneration. Nature communications, 2025 (PubMed: 41271711) [IF=16.6]

2). Multifunctional Injectable Microspheres Containing "Naturally-Derived" Photothermal Transducer for Synergistic Physical and Chemical Treating of Acute Osteomyelitis through Sequential Immunomodulation. ACS nano, 2024 (PubMed: 38335113) [IF=15.8]

3). Opsonization Inveigles Macrophages Engulfing Carrier-Free Bilirubin/JPH203 Nanoparticles to Suppress Inflammation for Osteoarthritis Therapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024 (PubMed: 38593402) [IF=15.1]

4). Regulation of immune microenvironments by polyetheretherketone surface topography for improving osseointegration. Journal of nanobiotechnology, 2025 (PubMed: 40069791) [IF=12.6]

5). Chemotherapy-elicited extracellular vesicle CXCL1 from dying cells promotes triple-negative breast cancer metastasis by activating TAM/PD-L1 signaling. Journal of experimental & clinical cancer research : CR, 2024 (PubMed: 38654356) [IF=11.3]

6). Muscle-derived factor alleviated cognitive impairment caused by intestinal ischemia-reperfusion. Redox biology, 2025 (PubMed: 40388874) [IF=10.7]

Application: WB    Species: Mouse    Sample: hippocampus

Fig. 10. Overexpression of TXNIP reverses the neuroprotective effects of irisin. (A) Representative trajectory maps from the MWM test. (B) Number of platform crossings during the probe trial (Data are presented as mean ± SD; n = 6; ∗∗P < 0.01, ##P < 0.01, &&P < 0.01). (C) Representative H&E staining images of the hippocampal CA1 region 48 h after II/R injury (n = 6; scale bars = 50 μm). (D) Quantification of normal neurons in the hippocampal CA1 region (Data are presented as mean ± SD; n = 6; ∗∗P < 0.01, ##P < 0.01, &&P < 0.01). (E) WB analysis of FNDC5, TXNIP, NLRP3, pro-caspase-1, and cleaved caspase-1 levels in the hippocampus of II/R mice after TXNIP overexpression. β-actin was used as loading control and all were referred to the same loading control. (F) Relative protein levels of FNDC5, TXNIP, NLRP3, pro-caspase-1, and cleaved caspase-1 in the hippocampus (Data are presented as mean ± SD; n = 6; ∗∗P < 0.01, ##P < 0.01, &&P < 0.01). (G) Schematic representation of the proposed mechanism. (H) WB analysis the levels of iNOS and Arg-1 in the hippocampus of II/R mice following TXNIP overexpression, β-actin was used as loading control and all were referred to the same loading control. (I) Relative protein levels of iNOS and Arg-1 in the hippocampus (β-actin was used as loading control and all were referred to the same loading control. Data are presented as mean ± SD; n = 6; ∗∗P < 0.01, ##P < 0.01, &&P < 0.01). (J) WB analysis of apoptosis-related molecules in the hippocampus of II/R mice following TXNIP overexpression. β-actin was used as loading control and all were referred to the same loading control. (K) Relative protein levels of apoptosis-related molecules in the hippocampus (Data are presented as mean ± SD; n = 6; ∗∗P < 0.01, #P < 0.05, ##P < 0.01, &&P < 0.01). (L) The concentrations of indicators related to lipid peroxidation in the hippocampus (Data are presented as mean ± SD; n = 6; ∗∗P < 0.01, ##P < 0.01, &&P < 0.01). (M) Quantitative analysis of pro-inflammatory cytokines concentrations in the hippocampus (Data are presented as mean ± SD; n = 6; ∗∗P < 0.01, #P < 0.05, ##P < 0.01, &&P < 0.01).

7). Inflammation-targeted nanoparticles modulate macrophage polarization for coronary therapy in Kawasaki disease. Journal of controlled release : official journal of the Controlled Release Society, 2025 (PubMed: 41135700) [IF=10.5]

8). Opsonized nanoparticles target and regulate macrophage polarization for osteoarthritis therapy: A trapping strategy. Journal of Controlled Release, 2022 (PubMed: 35489544) [IF=10.5]

9). Aligned electrospun poly(l-lactide) nanofibers facilitate wound healing by inhibiting macrophage M1 polarization via the JAK-STAT and NF-κB pathways. JOURNAL OF NANOBIOTECHNOLOGY, 2022 (PubMed: 35883095) [IF=10.2]

Application: WB    Species: Mice    Sample:

Fig. 2 The effect of aligned nanofibers on macrophage polarization. A Phalloidin staining of macrophages on electrospun membranes. Actin is stained green, and the nucleus is stained blue. B Flow cytometric analysis of macrophages. C qPCR analysis of M2 polarization-related genes. D ELISA analysis of IL-4 secretion. E qPCR analysis of M1 polarization-related genes (*p < 0.05, **p < 0.01, ***p < 0.001, n = 3). F Western blot analysis of macrophage polarization-related proteins. G and H Immunofluorescence analysis of CD86 and CD206 expression in macrophages. CD86 and CD206 are stained red, and the nucleus is stained blue

10). A novel multifunctional nanocomposite hydrogel orchestrates the macrophage reprogramming-osteogenesis crosstalk to boost bone defect repair. Journal of nanobiotechnology, 2024 (PubMed: 39533396) [IF=10.2]

Application: IF/ICC    Species: Rat    Sample: BMSCs

Fig. 6 Macrophage reprogramming-osteogenesis crosstalk effects of CTAG/GelMA hydrogels. (A) Schematic illustration of the macrophage reprogramming-osteogenesis crosstalk. (B) Arg 1 immunofluorescence staining. (C, D) ALP staining of BMSCs and macrophages co-cultured on hydrogel surface. (E) ALP activity assay. (F) Quantification of ALP staining. (G) Flow cytometry results of percentage of CD206+ cells. (H) Quantification of Arg 1 fluorescent staining. (I, J) ELISA for TNF-α and IL-10. (K) Mean fluorescence intensity of flow cytometric assays. (NS, no significant difference; *, P 

加载更多

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.